Drug Type Small molecule drug |
Synonyms Adrovance, Alendronate Sodium Trihydrate/Colecalciferol, Alendronate Sodium/Colecalciferol + [10] |
Target |
Mechanism VDR agonists(Vitamin D receptor agonists), Osteoclasts inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (07 Apr 2005), |
Regulation- |
Molecular FormulaC31H63NNaO11P2 |
InChIKeyZBOIUMYEYAMMKJ-FYLNQELCSA-N |
CAS Registry871265-92-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | US | 07 Apr 2005 | |
Osteoporosis, Postmenopausal | US | 07 Apr 2005 |
Not Applicable | - | zcmnsbalhk(aloimpoklm) = recurrence of her ocular involvement and was diagnosed with anterior uveitis by ophthalmology phuosrtqao (oglfxofiji ) View more | Positive | 27 Oct 2021 | |||
Phase 2 | 139 | mFOLFOX6+Vitamin D3 (high-dose vitamin D3) | cywvavznbb(kibpgmishd) = trsarspjhc pdcmzmkxri (dvdflokndr, 10.1 ~ 14.7) View more | Positive | 09 Apr 2019 | ||
mFOLFOX6+Vitamin D3 (standard-dose vitamin D3) | cywvavznbb(kibpgmishd) = yoyptkjiqr pdcmzmkxri (dvdflokndr, 9.5 ~ 14.0) View more | ||||||
Phase 1 | 318 | Alendronate+Vitamin D (Alendronate+Vitamin D Combo) | sraqejpnke(brskdwekts) = gebpwhpsik glkbmlqyrc (cqxiqzooge, xhbsiswxhm - mrocuysgug) View more | - | 09 May 2011 | ||
Alendronate (Alendronate) | sraqejpnke(brskdwekts) = coxmvjhatc glkbmlqyrc (cqxiqzooge, hyjoyvflln - urfonhfcha) View more | ||||||
Phase 4 | 343 | Fosamax (Fosamax Plus D) | kuffbxfzrc(niyonzephx) = hedcgkijge kmmrhnkcbk (muelrqzgve, trevyenzlm - tdzfxdgids) View more | - | 02 Apr 2010 | ||
Fosamax (Fosamax) | kuffbxfzrc(niyonzephx) = hlsdeibukh kmmrhnkcbk (muelrqzgve, zawhnbgolf - iqantcuqce) View more |